Related Experiment Video

Updated: Aug 6, 2025

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer
10:46

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer

Published on: September 13, 2022

3.7K

Detecting blood clots with aptamers: A potentially lifesaving new tool in medicine

John J Rossi1

  • 1Center for RNA Biology and Therapeutics, City of Hope, Monrovia, CA 91016, USA.

Molecular Therapy. Nucleic Acids
|March 17, 2023
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Aptamer-Based Target Detection Facilitated by a 3-Stage G-Quadruplex Isothermal Exponential Amplification Reaction
03:38

Aptamer-Based Target Detection Facilitated by a 3-Stage G-Quadruplex Isothermal Exponential Amplification Reaction

Published on: October 6, 2022

1.5K
Exploring Sequence Space to Identify Binding Sites for Regulatory RNA-Binding Proteins
11:34

Exploring Sequence Space to Identify Binding Sites for Regulatory RNA-Binding Proteins

Published on: August 9, 2019

6.7K

Related Experiment Videos

Last Updated: Aug 6, 2025

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer
10:46

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer

Published on: September 13, 2022

3.7K
Aptamer-Based Target Detection Facilitated by a 3-Stage G-Quadruplex Isothermal Exponential Amplification Reaction
03:38

Aptamer-Based Target Detection Facilitated by a 3-Stage G-Quadruplex Isothermal Exponential Amplification Reaction

Published on: October 6, 2022

1.5K
Exploring Sequence Space to Identify Binding Sites for Regulatory RNA-Binding Proteins
11:34

Exploring Sequence Space to Identify Binding Sites for Regulatory RNA-Binding Proteins

Published on: August 9, 2019

6.7K

Related Concept Videos

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

575
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
575

Articles linked to this work by shared authors, journal, and citation graph.

Revisiting long-standing biological questions through evolving technologies.

Bioscience trends·2026

RNA activation as a precision dosing modality: MTL-CEBPA for controlled enzyme elevation in MPS I-H.

Frontiers in medicine·2026

C/EBPβ stabilizes oxidative stress in triple-negative breast cancer cells, driving taxane resistance and immune evasion.

Molecular therapy : the journal of the American Society of Gene Therapy·2025

A hypoxia-responsive tRNA-derived small RNA confers renal protection through RNA autophagy.

Science (New York, N.Y.)·2025

Small RNAs as therapeutic agents: From catalytic motifs to regulatory pathways.

Molecular therapy : the journal of the American Society of Gene Therapy·2025

TIMEPOINT, a phase 1 study combining MTL-CEBPA with pembrolizumab, supports the immunomodulatory effect of MTL-CEBPA in solid tumors.

Cell reports. Medicine·2025

To scramble or not: Steric blocking 2'-MOE/PS control antisense oligonucleotides across cellular models.

Molecular therapy. Nucleic acids·2026

PCBP2 facilitates miR-93-5p-mediated repression of GDF11 in HCC cell lines.

Molecular therapy. Nucleic acids·2026

miRNA-34a-5p is a novel biomarker and modulator of the radioresponse in esophageal adenocarcinoma.

Molecular therapy. Nucleic acids·2026

Retraction Notice to: lncRNA TRMP-S directs dual mechanisms to regulate p27-mediated cellular senescence.

Molecular therapy. Nucleic acids·2026

Next-generation macrophage engineering in cancer therapy: From TAM reprogramming to CAR-macrophages.

Molecular therapy. Nucleic acids·2026

Retraction Notice to: Long Non-coding RNA Profiling Reveals an Abundant MDNCR that Promotes Differentiation of Myoblasts by Sponging miR-133a.

Molecular therapy. Nucleic acids·2026

Minicrush or T-Stenting and Minimal Protrusion in Complex Coronary Bifurcation Lesions: The Multicenter TREX Registry.

Circulation. Cardiovascular interventions·2026

False-Positive hs-cTnI in a Patient on Immunotherapy: a Case of Macromolecular Interference.

Clinical laboratory·2026

Highly sensitive electrochemical immunosensor for alpha-fetoprotein detection based on trimetallic metal-organic framework nanozymes with peroxidase-like activity.

Mikrochimica acta·2026

Construction of a New Lanthanide-Based Nanomaterial as Multifunctional Bio-Probes for in Vivo Imaging.

Journal of fluorescence·2026

[Strategies for Constructing a Technology Transfer System in Forensic Medicine Based on National Policies and Disciplinary Characteristics].

Fa yi xue za zhi·2026

Machine learning-assisted optimization of a BK7/Ag/As₂S₃/graphene surface plasmon resonance biosensor for high-sensitivity urine glucose detection.

Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us